Singapore, US researchers studying drug to treat haemorrhagic stroke

Assistant Professor Nicolas Kon from the National Neuroscience Institute and Associate Professor Michael Lucas James from Duke University School of Medicine are the lead researchers in the trials.
Assistant Professor Nicolas Kon from the National Neuroscience Institute and Associate Professor Michael Lucas James from Duke University School of Medicine are the lead researchers in the trials. PHOTO: NATIONAL NEUROSCIENCE INSTITUTE
New: Gift this subscriber-only story to your friends and family

Non-surgical treatment for people who have suffered a more severe form of haemorrhagic stroke could be on the cards if trials here and in the United States prove successful.

Researchers are testing a protein-based compound that reduces inflammation in the brain after injury. It would complement existing treatment for the affliction, which makes up about one-fifth of all stroke cases here but caused 44 per cent of all stroke-related deaths in 2016.

Already a subscriber? 

Dive deeper at $0.99/month

Want more exclusives, sharp insights into what's happening at home and abroad? Subscribe to stay informed.

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • 2-week e-paper archive so you never miss out on any topic that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.

A version of this article appeared in the print edition of The Straits Times on April 10, 2019, with the headline Singapore, US researchers studying drug to treat haemorrhagic stroke. Subscribe